top
Search terms
Results 1 - 10 of 22 - ordered by :
Pages: 1 2 3
Ejhf

Background No pooled analysis has been undertaken to assess the efficacy and safety of the non-vitamin K antagonist oral anticoagulants (NOACs) compared with warfarin in the subgroup of patients with ...

European Journal of Heart Failure, Xiong, Qinmei, Lau, Yee Cheng, Senoo, Keitaro, Lane, Deirdre A., Hong, Kui, Lip, Gregory Y.H.

Date : 01/11/2015 Item size : 49029 bytes
Ejhf

L. Fauchjier, Tel: +33 2 47 47 46 50, Fax: +33 6 65 17 30 82, Email: lfau@med.univ-tours.fr or G.Y.H. Lip, Tel: +44 121 507 5080, Fax: +44 121 554 4083, Email: g.y.h.lip@bham.ac.uk Search for more ...

European Journal of Heart Failure, Banerjee, Amitava, Taillandier, Sophie, Olesen, Jonas Bjerring, Lane, Deirdre A., Lallemand, Benedicte, Lip, Gregory Y.H., Fauchier, Laurent

Date : 01/03/2012 Item size : 193446 bytes
Ejhf

An increased risk of venous thrombo-embolism (VTE), cardioembolic stroke, and sudden death occurs in ~ 30% of HF patients and may contribute to the high mortality and morbidity seen in HF. [4] Given ...

European Journal of Heart Failure, Lip, Gregory Y.H., Ponikowski, Piotr, Andreotti, Felicita, Anker, Stefan D., Filippatos, Gerasimos, Homma, Shunichi, Morais, Joao, Pullicino, Patrick, Rasmussen, ...

Date : 01/07/2012 Item size : 373175 bytes
Ehjournal

In the second of a two-part review, we discuss the use of NOAC for stroke prevention in the following subgroups of patients with AF: (vii) secondary stroke prevention in patients after stroke or ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 09/03/2017
Ehjournal

In the first of a two-part review, we discuss the choice of NOAC for stroke prevention in the following subgroups of patients with AF: (i) stable coronary artery disease or peripheral artery disease, ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 09/03/2017 Item size : 483367 bytes
Ehjournal

[...]clinical trials of antithrombotic therapy in patients with AF have rightly included bleeding events as part of the composite primary endpoint, as treatment decisions should be based upon net ...

European Heart Journal, Lane, Deirdre A., Lip, Gregory Y.H.

Date : 01/09/2010
Ehjournal

After adjusting for stroke risk factors, patients with CrCl <60 mL/min had more than two-fold higher risk of stroke/SE and almost 60% higher risk of major bleeding compared with those with CrCl ...

European Heart Journal, Apostolakis, Stavros, Guo, Yuotao, Lane, Deirdre A., Buller, Harry, Lip, Gregory Y.H.

Date : 07/12/2013
Ehjournal

If a VKA is used, good quality anticoagulation control, defined as a time in therapeutic range (TTR) >70%, is crucial, given that the efficacy and (particularly) safety of VKA is intimately related ...

European Heart Journal, Lip, Gregory Y.H., Lane, Deirdre A.

Date : 07/12/2015 Item size : 142162 bytes
Ehjournal

In the second of a two-part review, we discuss the use of NOAC for stroke prevention in the following subgroups of patients with AF: (vii) secondary stroke prevention in patients after stroke or ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 21/03/2017
Ehjournal

In the first of a two-part review, we discuss the choice of NOAC for stroke prevention in the following subgroups of patients with AF: (i) stable coronary artery disease or peripheral artery disease, ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 21/03/2017 Item size : 490669 bytes